Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01KKU
|
||||
Former ID |
DNC009282
|
||||
Drug Name |
NSC-94258
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529519] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H10O3
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3)O
|
||||
InChI |
1S/C15H10O3/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-9,16H
|
||||
InChIKey |
MQGPSCMMNJKMHQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Aldose reductase | Target Info | Inhibitor | [525506] | |
Cytochrome P450 19 | Target Info | Inhibitor | [530867] | ||
Estradiol 17 beta-dehydrogenase 1 | Target Info | Inhibitor | [529519] | ||
WikiPathways | Metapathway biotransformation | ||||
Polyol Pathway | |||||
Metabolism of steroid hormones and vitamin DWP702:Metapathway biotransformation | |||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Ovarian Infertility Genes | |||||
Metabolism of steroid hormones and vitamin D | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compoundsWP496:Steroid Biosynthesis | |||||
Prostate Cancer | |||||
References | |||||
Ref 525506 | J Med Chem. 1999 Jun 3;42(11):1881-93.1-Benzopyran-4-one antioxidants as aldose reductase inhibitors. | ||||
Ref 529519 | J Med Chem. 2008 Jul 24;51(14):4188-99. Epub 2008 Jun 6.Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries. | ||||
Ref 530867 | Bioorg Med Chem Lett. 2010 May 15;20(10):3050-64. Epub 2010 Apr 8.Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.